Neuroone Medical Technologies (NMTC) EBT (2010 - 2026)

Neuroone Medical Technologies has disclosed EBT across 17 years of filings, most recently posting -$2.4 million for Q1 2026.

• Quarterly EBT fell 4.91% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (down 5.1% YoY) and the FY2025 annual result came in at -$3.6 million, up 70.73% from the prior year.
• EBT slipped to -$2.4 million in Q1 2026, from -$1.4 million in the prior quarter.
• Across five years, EBT topped out at $1.8 million in Q4 2024 and bottomed at -$3.5 million in Q1 2023.
• The 5-year median for EBT is -$2.8 million (2022), against an average of -$2.3 million.
• Year-over-year, EBT jumped 153.37% in 2024 and sank 180.54% in 2025.
• Neuroone Medical Technologies' EBT stood at -$1.7 million in 2022, then sank by 93.04% to -$3.3 million in 2023, then jumped by 153.37% to $1.8 million in 2024, then plunged by 180.54% to -$1.4 million in 2025, then sank by 65.66% to -$2.4 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$2.4 million, -$1.4 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.